Cannabis Use: Clinical Trials

20 trials for Cannabis Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting, 5 completed, 5 not yet recruiting, 1 unknown. 20 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 120Recruiting 8, Completed 5, Not yet recruiting 5, Unknown 1, Withdrawn 1
Phase 24Recruiting 2, Completed 1, Not yet recruiting 1

Follow Cannabis Use: new trials by email Literature Review of Cannabis Use trials Research Report on Cannabis Use

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behavioral Pharmacology of THC and Beta-Myrcene
Placebo, THC, Beta-Myrcene - Cannabis Use
Phase 1Not yet recruitingJohns Hopkins University322027-07-012026-07-31
Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
Cannabis - Cannabis Use, Impaired Driving
Phase 1Not yet recruitingJohns Hopkins University402026-12-012026-10-16
Cannabis and Opioid Use Disorder, Study 2
Inhaled Cannabis, Intranasal Opioid - Opioid Use Disorders, Cannabis Use
Phase 1Not yet recruitingUniversity of Kentucky1002026-11-302026-10-09
Cannabis Effects on Opioid Self-Administration
Cannabis, Placebo Cannabis, Intranasal Opioid Agonist - Opioid Use Disorder, Cannabis Use
Phase 1Not yet recruitingShanna Babalonis, PhD302026-11-302026-10-14
Acute Effects of Cannabis on Cognition and Affect
THC 20mg, Placebo - Cannabis Use
Phase 1RecruitingWashington State University922026-09-112026-10-29
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery
Cannabidiol (CBD) only, Placebo only, Delta-9-tetrahydrocannabinol (THC) only - PTSD, Post Traumatic Stress Disorder
Phase 1 / Phase 2Not yet recruitingLeslie Lundahl2802026-09-012026-08-26
Warrior CARE: Cannabis Behavioral Health
Tetrahydrocannabinol, Cannabidiol, Placebo - Post Traumatic Stress Disorder, Cannabis Use
Phase 1 / Phase 2RecruitingWayne State University5002025-09-222026-08-07
Effect of Cannabis on E-Cigarette Use Behavior
THC High Dose, THC Low Dose, THC 0mg - Cannabis Use, Tobacco Use
Phase 1RecruitingJohns Hopkins University1002025-03-192026-04-09
Effect of Cannabis on Cigarette Use Behavior
THC 30mg, THC 5mg, THC 0mg - Cannabis Use, Tobacco Use
Phase 1RecruitingJohns Hopkins University1002025-01-222026-01-16
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Information Motivation Behavioral and Motivational Interviewing (IMB-MI) technique - Hiv, Alcohol Drinking
Phase 1RecruitingYale University1002025-01-152026-09-25
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
Placebo, Choline - Child Development, Cannabis Use
Phase 1RecruitingUniversity of Colorado, Denver1402024-11-252025-02-03
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Cannabis, Placebo - Cannabis Use
Phase 1RecruitingJohns Hopkins University802024-07-102026-04-13
SV2A in Older Adults
[11C]UCB-J PET - Cannabis Use
Phase 1 / Phase 2RecruitingYale University242022-07-062026-10-20
Marijuana Effects on Simulated Driving Performance
Marijuana, Alcohol, placebo alcohol - Cannabis, Cannabis Use
Phase 1CompletedShanna Babalonis, PhD102019-07-012024-07-31
Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation
Cannabis decoction, Cannabis oil, Vaporized cannabis - Cannabis Use, Healthy Subjects
Phase 1CompletedGermans Trias i Pujol Hospital432018-12-102021-04-12
Neural Correlates of Driving and Cannabis
Cannabis - Cannabis Use, Driving Impaired
Phase 1UnknownUnity Health Toronto122018-08-082020-03-23
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
Lorcaserin, Placebo, Marijuana - Cannabis Use
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute152017-09-052022-07-26
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
Placebo + Placebo, Oral Cannabis + Placebo, Placebo + Inhaled Cannabis - Cannabis Use
Phase 1CompletedNational Institute on Drug Abuse (NIDA)282014-06-142019-12-16
Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis
Cannabis Cigarette - Cannabis Use, Drug Abuse
Phase 1CompletedNational Institute on Drug Abuse (NIDA)452010-01-222018-07-05
Pilot Study Repetitive Transcranial Magnetic Stimulation (rTMS) in Cannabis Craving
Repetitive Transcranial Magnetic Stimulation - Cannabis Use
Phase 1WithdrawnNational Institute on Drug Abuse (NIDA)2009-08-192017-07-02

Narrower conditions

Marijuana Abuse (11)  ·  Alcohol Drinking (2)  ·  Opioid-Related Disorders (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Suicide (2)  ·  Tobacco Use (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Cigarette Smoking (1)  ·  Cognitive Dysfunction (1)  ·  Substance-Related Disorders (1)  ·  Vaping (1)

Broader conditions

Mental Disorders (13)  ·  Chemically-Induced Disorders (12)  ·  Substance-Related Disorders (11)  ·  Behavior (6)  ·  Behavioral Symptoms (2)  ·  Drinking Behavior (2)  ·  Narcotic-Related Disorders (2)  ·  Self-Injurious Behavior (2)  ·  Smoking (2)  ·  Stress Disorders, Traumatic (2)  ·  Trauma and Stressor Related Disorders (2)  ·  Blood-Borne Infections (1)  ·  Cognition Disorders (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)

Interventions

nabiximols (10)  ·  Dronabinol (6)  ·  Cannabidiol (2)  ·  Analgesics, Opioid (1)  ·  Choline (1)  ·  Ethanol (1)  ·  Exercise (1)  ·  Methods (1)  ·  Motivational Interviewing (1)  ·  Phosphatidylcholines (1)  ·  Rice Bran Oil (1)  ·  Single Person (1)  ·  Transcranial Magnetic Stimulation (1)  ·  beta-myrcene (1)  ·  lorcaserin (1)

Sponsors

Johns Hopkins University (5)  ·  National Institute on Drug Abuse (NIDA) (3)  ·  Shanna Babalonis, PhD (2)  ·  Yale University (2)  ·  Germans Trias i Pujol Hospital (1)  ·  Leslie Lundahl (1)  ·  New York State Psychiatric Institute (1)  ·  Unity Health Toronto (1)  ·  University of Colorado, Denver (1)  ·  University of Kentucky (1)  ·  Washington State University (1)  ·  Wayne State University (1)

Countries

United States (18)  ·  Canada (1)  ·  Spain (1)

Top investigators

Dustin Lee, PhD (2)  ·  Marilyn Huestis, Ph.D. (2)  ·  Shanna Babalonis, PhD (2)  ·  Amy C Justice, MD, PhD (1)  ·  Carrie Cuttler, PhD (1)  ·  Deepak C D'Souza, MBBS, MD (1)  ·  Dustin C Lee, PhD (1)  ·  M. Camille Hoffman, MD (1)  ·  Ryan J McLaughlin, PhD (1)  ·  Ryan Vandrey, PhD (1)  ·  Sharon Hunter, PhD (1)  ·  Tom Schweizer, PhD (1)  ·  Tory Spindle, PhD (1)

Results publications

PMID 27899456, PMID 28138971, PMID 28188235, PMID 33155722, PMID 33298281, PMID 33322849, PMID 33451073

NIH funding

R01DA058624 (2), P01AA029545 (1), R01DA043475 (1), R01DA057201 (1), R21DA045101 (1), R21DA056687 (1)